Stock Scorecard



Stock Summary for 23andMe Holding Co - Class A (ME) - $0.51 as of 3/28/2024 2:38:03 PM EST

Total Score

13 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ME

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ME

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ME

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for ME

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for ME

23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 3/20/2024 11:30:00 AM
A Few Years From Now, You'll Probably Wish You'd Followed Billionaire Investors Into This Stock 3/16/2024 9:30:00 AM
End Adoption Secrecy 3/11/2024 11:31:00 AM
TeamOhana triples revenue helping companies achieve profitable growth and avoid layoffs with all-in-one headcount platform 3/7/2024 2:00:00 PM
Planful Named to Constellation Research ShortList™ for Cloud-Based Planning and Performance Management Platforms for 12th Consecutive Year 3/6/2024 5:08:00 PM
BETR ADDS $15 MILLION IN STRATEGIC EQUITY FINANCING TO FURTHER ACCELERATE ITS SPORTS GAMING AND MEDIA BUSINESSES 3/6/2024 2:00:00 PM
BETR ADDS $15 MILLION IN STRATEGIC EQUITY FINANCING TO FURTHER ACCELERATE ITS SPORTS GAMING AND MEDIA BUSINESSES 3/6/2024 2:00:00 PM
23andMe Launches New Genetic Reports on Common Forms of Cancer 3/6/2024 12:30:00 PM
23andMe Launches New Genetic Reports on Common Forms of Cancer - 23andMe Holding ( NASDAQ:ME ) 3/6/2024 12:30:00 PM
23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research ( AACR ) Annual Meeting 2024 - 23andMe Holding ( NASDAQ:ME ) 3/5/2024 9:30:00 PM

Financial Details for ME

Company Overview

Ticker ME
Company Name 23andMe Holding Co - Class A
Country USA
Description 23andMe, Inc., a consumer genetics and research company, is dedicated to developing a genetic database to unlock knowledge that leads to rapid discovery of new drug development targets. The company is headquartered in Sunnyvale, California with an additional office in Mountain View, California.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/26/2024

Stock Price History

Last Day Price 0.51
Last Day Price Updated 3/28/2024 2:38:03 PM EST
Last Day Volume 0
Average Daily Volume 7,440,895
52-Week High 2.32
52-Week Low 0.40
Last Price to 52 Week Low 27.50%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -4.22
Free Cash Flow Ratio 0.66
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 2.15
Total Cash Per Share 0.77
Book Value Per Share Most Recent Quarter 0.78
Price to Book Ratio 0.62
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 0.95
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 315,436,000
Market Capitalization 160,872,360
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -43.30%
Reported EPS 12 Trailing Months -1.11
Reported EPS Past Year -0.55
Reported EPS Prior Year -0.51
Net Income Twelve Trailing Months -521,968,000
Net Income Past Year -311,656,000
Net Income Prior Year -217,490,000
Quarterly Revenue Growth YOY -33.20%
5-Year Revenue Growth 10.15%

Balance Sheet

Total Cash Most Recent Quarter 242,418,000
Total Cash Past Year 242,418,000
Total Cash Prior Year 386,849,000
Net Cash Position Most Recent Quarter 242,418,000
Net Cash Position Past Year 242,418,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 377,188,000
Total Stockholder Equity Prior Year 713,939,000
Total Stockholder Equity Most Recent Quarter 377,188,000

Options

Put/Call Ratio 0.03
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.06
MACD Signal -0.06
20-Day Bollinger Lower Band 0.38
20-Day Bollinger Middle Band 0.72
20-Day Bollinger Upper Band 1.06
Beta 1.29
RSI 40.57
50-Day SMA 1.21
200-Day SMA 0.00

System

Modified 3/29/2024 1:06:43 AM EST